Capabilities for Your Project
The Roswell Park Advantage
Collaborating with the Roswell Park GMP Engineering & Cell Manufacturing Facility grants you access to our comprehensive suite of world-class biopharmaceutical services. Our operations are grounded in robust platforms and established processes, strategically designed to eliminate bottlenecks and optimize outcomes.
We are constructing an ecosystem that seamlessly integrates the collective expertise of Roswell Park across diverse departments, spanning from cell biology and cytogenetics to molecular biology and beyond. Engage with us to harness this integrated approach and leverage the full spectrum of our biopharmaceutical services for the success of your projects.
Innovative Science & Technology
Clinical Manufacturing
Ensure the secure, scalable, and agile manufacturing of cell and gene therapy products, encompassing Chimeric Antigen Receptor (CAR) T-cells, engineered TCRs, dendritic cell vaccines, and more. Partner with us to leverage our expertise in delivering safe and scalable production for a diverse range of cell and gene therapy applications.
Viral Vectors
Access lentivirus (LV) and gamma-retroviral (RV) vectors, tailored for both research and clinical applications. Partner with us to secure top-quality vectors designed to meet the rigorous standards required for research and clinical use.
CAR T-Cell Design, Development & Production
Comprehensive CAR T-cell therapy solutions from start to finish, featuring specialized expertise in CAR and viral vector design, along with cell engineering. Engage with us to leverage our end-to-end capabilities for the success of your CAR T-cell therapy initiatives.
Process Development
Streamlining the manufacturing process to align with regulatory standards, guaranteeing the safety and efficacy of your innovative therapy. Engage with us to optimize your manufacturing processes and ensure compliance with stringent regulatory requirements.
Experience Matters
Over a decade of experience in clinical manufacturing. Engage with us to benefit from our extensive expertise and proven track record in this field.
Moving a scientific concept from ideation to commercialization requires a carefully coordinated intersection of many disciplines with vast experience and expertise. The depth and breadth of our GMP facility capabilities and the team we have assembled highlights our commitment to being at the forefront of research and medical innovation — and enables the success of our partners in advancing effective cell therapy technologies.
Yeong “Christopher” Choi, PhD, MBA Technical Director, GMP Facility